Hims & Hers' upcoming Q2 2026 earnings call on August 10 will likely focus on the company's pivot to branded GLP-1 weight-loss medications after halting compounded versions, which contributed to a Q1 net loss amid a revenue beat at $608 million and subscriber growth to 2.6 million. Traders are watching for updates on acceleration from this shift, revised full-year guidance, and early traction from the newly launched Hers app featuring doctor-led, AI-native care experiences. Competitive pressures in telehealth, international expansion via acquisitions like Zava, and the path to 2027 profitability remain key swing factors, with management emphasizing durable platform growth beyond weight management.
Tóm tắt AI thử nghiệm tham chiếu dữ liệu Polymarket. Đây không phải tư vấn giao dịch và không ảnh hưởng đến cách thị trường này được giải quyết. · Cập nhậtMỚI
Aug 10, 2026
Quarter 20+ times
95%
Subscriber 15+ times
78%
Platform 10+ times
95%
Fiscal 10+ times
4%
Peptide 5+ times
61%
GLP-1
95%
Testosterone
93%
Eucalyptus
89%
Longevity
80%
Wearable
73%
Europe
60%
Amazon
26%
Regulation
26%
-No Qualifying Event-
6%
$385 KL.
Quarter 20+ times
$38 KL.
95%
Subscriber 15+ times
$0 KL.
78%
Platform 10+ times
$52 KL.
95%
Fiscal 10+ times
$60 KL.
4%
Peptide 5+ times
$0 KL.
61%
GLP-1
$0 KL.
95%
Testosterone
$0 KL.
93%
Eucalyptus
$0 KL.
89%
Longevity
$0 KL.
80%
Wearable
$71 KL.
73%
Europe
$61 KL.
60%
Amazon
$0 KL.
26%
Regulation
$0 KL.
26%
-No Qualifying Event-
$103 KL.
6%
This market will resolve based on the next earnings announcement of Hims currently scheduled to take place on August 10, 2026 at 5:00 PM ET.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
If this event is definitely cancelled, or otherwise is not aired by August 11, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Event+Mentions+Contract+DeFi.pdfHims & Hers' upcoming Q2 2026 earnings call on August 10 will likely focus on the company's pivot to branded GLP-1 weight-loss medications after halting compounded versions, which contributed to a Q1 net loss amid a revenue beat at $608 million and subscriber growth to 2.6 million. Traders are watching for updates on acceleration from this shift, revised full-year guidance, and early traction from the newly launched Hers app featuring doctor-led, AI-native care experiences. Competitive pressures in telehealth, international expansion via acquisitions like Zava, and the path to 2027 profitability remain key swing factors, with management emphasizing durable platform growth beyond weight management.
This market will resolve based on the next earnings announcement of Hims currently scheduled to take place on August 10, 2026 at 5:00 PM ET.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
If this event is definitely cancelled, or otherwise is not aired by August 11, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Event+Mentions+Contract+DeFi.pdf
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
If this event is definitely cancelled, or otherwise is not aired by August 11, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Event+Mentions+Contract+DeFi.pdf
Thị trường mở: Aug 7, 2026, 7:02 PM ET
Khối lượng
$385Ngày kết thúc
Aug 10, 2026Thị trường mở
Aug 7, 2026, 7:02 PM ETResolver
0x65070BE91...This market will resolve based on the next earnings announcement of Hims currently scheduled to take place on August 10, 2026 at 5:00 PM ET.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
If this event is definitely cancelled, or otherwise is not aired by August 11, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Event+Mentions+Contract+DeFi.pdfHims & Hers' upcoming Q2 2026 earnings call on August 10 will likely focus on the company's pivot to branded GLP-1 weight-loss medications after halting compounded versions, which contributed to a Q1 net loss amid a revenue beat at $608 million and subscriber growth to 2.6 million. Traders are watching for updates on acceleration from this shift, revised full-year guidance, and early traction from the newly launched Hers app featuring doctor-led, AI-native care experiences. Competitive pressures in telehealth, international expansion via acquisitions like Zava, and the path to 2027 profitability remain key swing factors, with management emphasizing durable platform growth beyond weight management.
This market will resolve based on the next earnings announcement of Hims currently scheduled to take place on August 10, 2026 at 5:00 PM ET.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
If this event is definitely cancelled, or otherwise is not aired by August 11, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Event+Mentions+Contract+DeFi.pdf
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
If this event is definitely cancelled, or otherwise is not aired by August 11, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Event+Mentions+Contract+DeFi.pdf
Khối lượng
$385Ngày kết thúc
Aug 10, 2026Thị trường mở
Aug 7, 2026, 7:02 PM ETResolver
0x65070BE91...Hims & Hers' upcoming Q2 2026 earnings call on August 10 will likely focus on the company's pivot to branded GLP-1 weight-loss medications after halting compounded versions, which contributed to a Q1 net loss amid a revenue beat at $608 million and subscriber growth to 2.6 million. Traders are watching for updates on acceleration from this shift, revised full-year guidance, and early traction from the newly launched Hers app featuring doctor-led, AI-native care experiences. Competitive pressures in telehealth, international expansion via acquisitions like Zava, and the path to 2027 profitability remain key swing factors, with management emphasizing durable platform growth beyond weight management.
Tóm tắt AI thử nghiệm tham chiếu dữ liệu Polymarket. Đây không phải tư vấn giao dịch và không ảnh hưởng đến cách thị trường này được giải quyết. · Cập nhật
Cẩn thận với liên kết bên ngoài.
Cẩn thận với liên kết bên ngoài.
Câu hỏi thường gặp